CHM 0.00% 1.4¢ chimeric therapeutics limited

Ann: Notice of Extraordinary General Meeting/Proxy Form, page-100

  1. 12,208 Posts.
    lightbulb Created with Sketch. 6222
    Great article here , sn4ll c4ps

    Chimeric Therapeutics receives ethics approval for CHM CDH17 gastrointestinal cancer trial

 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.